LRRK2 and Parkinson disease: In addition, miR-19b-3p and miR-24, which are frequently downregulated in PD, target LRRK2 and promote its overexpression, further enhancing NF-κB-mediated neuroinflammation through the production of proinflammatory cytokines such as TNF-α and IL-1β.